| Name | A2ti-2 |
|---|
| Description | A2ti-2 is a selective and low-affinity annexin A2/S100A10 heterotetramer (A2t) inhibitor with an IC50 of 230 μM[1]. A2ti-2 specifically disrupts the protein-protein interaction (PPI) between A2 and S100A10. A2ti-2 prevents human papillomavirus type 16 (HPV16) infection[2]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 230 μM (A2t)[1] |
| In Vitro | A2ti-2 (compound 7a) is an annexin A2-S100A10 protein-protein interaction blocker[1]. A2ti-2 is less effective with <50% reduction in HPV16 PsV infection achieved at 100 μM. A2ti-1 decreases HPV16 entry with a 20% reduction at 100 μM[2]. |
| References |
| Molecular Formula | C18H18N4O2S |
|---|---|
| Molecular Weight | 354.43 |